İsimsiz @science-tv-blog - Tumblr Blog

New Post has been published on science.tv.tr

New Post has been published on http://science.tv.tr/2016/06/28/bus-passengers-with-visual-or-hearing-impairments-get-helping-wristband/

Bus passengers with visual or hearing impairments get helping wristband

To make use of the ViBus proof-of-idea prototype wristband, a passenger requiring help tells the driving force his or her vacation spot. The driving force faucets the wristband’s quantity into the ViBus app, together with the vacation spot particulars after which the passenger places it on.

By way of WiFi and Bluetooth connection, a sign is distributed to the machine to make it vibrate and flash on the proper time for the passenger to alight.

Though the idea is easy, to make the wristband sensible and commercially viable Primasil mentioned it needed to meet difficult design imperatives to make sure the band is discreet, compact, an excellent match, and ergonomically straightforward to placed on and take away.

It was additionally important that the silicone membrane needs to be sufficiently clear to transmit the machine’s LED lights, in response to the corporate.

Cell Onboard director, Corbin Adler stated: “That is the primary time we now have used our fast prototyping services for a mission with silicone rubber as a key design ingredient.

“We had heard that Primasil’s strategy was out of the extraordinary and with a responsive ‘can do’ angle they shortly recognized the simplest silicone rubber answer for our undertaking. It was clear that Primasil understood and centered on the business and sensible wants.”

He added: “The proof of idea prototype has now been efficiently trialled in Nottingham and subsequent steps embrace just a few minor variations and industrial concerns below the remit of our companions Transport Programs Catapult, alongside the Division of Transport.”

Primasil’s managing director, Steve Wheeler, mentioned: “As Cellular Onboard has found, silicone rubber affords companies a complete new world of alternative.

“We’ve been delighted to work with Cellular Onboard on such a worthwhile challenge and we stay up for seeing how this gadget makes a distinction to folks’s lives.”

New Post has been published on science.tv.tr

New Post has been published on http://science.tv.tr/2016/06/27/philips-handheld-device-diagnoses-heart-attacks-with-one-drop-of-blood/

Philip's handheld device diagnoses heart attacks with one drop of blood

The Minicare I-20 system

Consequently, sufferers with chest ache presenting on the emergency division are set to learn from this innovation, which Philips mentioned it has not too long ago CE marked for compliance with the European in vitro diagnostic medical units directive.

The hand-held Minicare I-20 system measures the extent of cardiac troponin I (cTnI), a protein that’s excreted by the center muscle into the blood following a coronary heart assault.

It delivers check outcomes, comparable with these obtained by laboratory testing, in lower than 10 minutes close to the affected person, lowering the time for a doctor to resolve on the suitable therapy pathway, in response to the corporate.

The Minicare I-20 system consists of a related handheld analyser, software program and a single-use disposable cartridge containing an software particular take a look at based mostly on Philips’ proprietary biosensor expertise.

Marcel van Kasteel, CEO of handheld diagnostics at Philips, stated: “The industrial launch of the Minicare I-20 system for cardiac troponin I testing represents a serious milestone for us.

“I’m satisfied that we will make an actual distinction for sufferers and care suppliers.

“Minicare I-20 is designed to assist care suppliers scale back each the time-to-remedy and time-to-discharge of sufferers, thereby serving to to cut back crowding in emergency departments and enhance the utilisation of hospital sources.”

Paul Collinson, guide chemical pathologist at St George’s College Hospitals NHS Basis Belief, mentioned: “Blood samples are often analysed within the hospital laboratory, and it may simply take greater than an hour to get the end result again to the emergency division doctor.

“Level-of-care testing can considerably assist to cut back the turnaround time.”

The Minicare I-20 was examined in actual-life acute care settings inside the European Lab2Go challenge, a consortium of European hospitals.

The research confirmed the potential of Philips Minicare cTnI system to precisely measure cTnI values, close to the affected person within the emergency division, with a turnaround time of lower than 10 minutes.

The brand new check is being launched in chosen nations in Europe together with the UK, Germany, the Netherlands and Belgium.

New Post has been published on science.tv.tr

New Post has been published on http://science.tv.tr/2016/06/25/new-bills-reform-medical-device-review-processes/

New bills reform medical device review processes

Congressman Mike Fitzpatrick and Congresswoman Louise Slaughter introduced the introduction of the Ariel Grace’s Legislation and the Medical System Guardians Act earlier this week.

Fitzpatrick stated: “Whereas many medical units show lifesaving, we all know that some could cause hurt and have devastating penalties on sufferers.

“I believe everybody would agree that when a medical system is discovered to be unsafe, there must be an efficient course of in place to trace these failures, to take away units from the market and supply authorized recourse for these impacted.”

The Ariel Grace’s Legislation permits sufferers negatively effected by defective medical units to hunt authorized recourse and ensures medical machine producers are incentivised to take care of the most secure and only merchandise for all sufferers.

This legislation comes into place after the everlasting sterilisation machine Essure led to the dying of at the least 4 ladies and almost 300 unborn youngsters, together with Ariel Grace who was stillborn following failure of the system, according to Slaughter.

The Medical Gadget Guardians Act codifies an current mandate of the American Medical Affiliation’s Code of Medical Ethics, which recognises that physicians are in the very best place to determine and report unsafe units.

This legislation happened after laparoscopic energy morcellators, used for hysterectomies and to deal with uterine fibroids, hit an undetectable fibroid most cancers and unfold the most cancers all through the physique, like shrapnel – taking Stage 1 most cancers instantly to Stage four.

Regardless of there being events the place this fault had beforehand occurred, nobody reported this defect to the Meals and Drug Administration (FDA) till a physician underwent morcellation and her most cancers unfold all through her physique. The lady submitted her affected person report back to the FDA.

This was the primary adversarial occasion report acquired by the FDA concerning morcellators, regardless of the identical hospital having a affected person harmed by a morcellator one yr earlier, in accordance with Slaughter.

Slaughter mentioned: “These payments are about saving lives. We’ve seen firsthand how devastating it’s when a medical machine has an unintended, hostile consequence. It’s time for Congress to make commonsense modifications to guard sufferers and provides them the knowledge that might assist save lives.”

New Post has been published on science.tv.tr

New Post has been published on http://science.tv.tr/2016/06/24/needle-free-drug-delivery-devices-market-will-be-worth-10bn-by-2024/

Needle-free drug delivery devices market will be worth £10bn by 2024

The rising prevalence of continual ailments akin to Hepatitis B, Hepatitis C, and AIDS because of the intensive use of injections is a potent driver of the needle-free drug supply units market, Grand View Analysis mentioned.

Moreover, the report highlighted that the rising want for self-administration of medication as within the case of diabetes and ache-free drug supply have consequentially boosted the trade share of needle-free drug supply units.

Managed dosing capability, minimal harm to pores and skin and speedy drug administration are the important thing related advantages driving the doctor desire thereby fueling the demand for the market and rising concentrate on the event of transportable needle-free drug supply units, the research confirmed.

These aforementioned benefits associated to needle-free drug supply units are anticipated to function key driving components spurring the expansion of the needle-free drug supply gadgets market over the forecast interval.

Additional findings from the examine reveal:

Jet injectors dominated the know-how section with a market share of over 30.zero%, with respect to income in 2015, owing to its excessive utilization fee and vast applicability in delivering a wide variety of medication.

On the idea of utility, the insulin supply units section held the most important share of over 33.zero% in 2015 owing to the excessive demand for painless insulin supply by sufferers coupled with the requirement of insulin at common intervals in diabetic sufferers, thus facilitating the expansion of this phase. As per the WHO, the worldwide diabetes prevalence is rising at a price of eight.5%, thereby propelling the demand for needle-free insulin supply units.

New Post has been published on science.tv.tr

New Post has been published on http://science.tv.tr/2016/05/27/omnicell-helps-nhs-trusts-manage-medical-inventory/

Omnicell helps NHS Trusts manage medical inventory

Omnicell UK and Ireland has announced new contracts with five hospital Trusts in the wake of the Lord Carter report

× Expand

The five new business contracts will see automated medical supply systems being installed in Wye Valley Trust (Hereford), Maidstone and Tunbridge Wells, Southampton, Burton and Gateshead where they will manage a combined total of £20m of stock. All five installations will go live in the coming summer.

The Lord Carter report highlighted that Trusts spend around £9bn on procurement of goods and services, £6bn of which is spent by the acute sector. Around a third of this is spent on medical consumables and a third on high-cost medical devices.

However Lord Carter believes that there are greater savings to be had by managing the demand for products via better inventory management systems.

The report stated that: “Very few trusts are able to demonstrate even a basic level of control or visibility over total inventory or purchase order compliance that is common practice in other health systems and industry sectors such as retail”. It went on to suggest that a target saving of £700m to £1bn savings on the £9bn procurement spend was realistic.

Omnicell said its inventory management solutions allow Trusts to manage and control the usage of medical supplies throughout hospitals. The solutions include secure closed cabinets and open scanning systems which track inventory in real time and cost product usage to patients, healthcare consultants and procedures.

This data provides Trust management teams with visibility of patient-costing and allows them to benchmark and analyse hospital costs, according to Omnicell.

Paul O’Hanlon, managing director for Omnicell, UK and Ireland said: “Our existing partnerships with NHS Trusts has enabled us to see first-hand the results supplies management technology can bring.

“As a GS1 member we are helping these five Trusts to implement and realise their GS1 vision.

“We very much look forward to working with these five Trusts to automate supplies in their hospital to drive cost savings and efficiencies and ensure a real and sustainable future for our NHS.”

New Post has been published on science.tv.tr

New Post has been published on http://science.tv.tr/2016/05/27/boston-scientific-hits-high-first-quarter-profits/

Boston Scientific hits high first quarter profits

Boston Scientific reports that its first quarter profits were better than it had expected and has now raised its full-year revenue forecast

× Expand

Boston Scientific generated sales of £1.349bn ($1.964bn) during the first quarter ended March 31 2016, compared to the company's guidance range for the quarter of £1.298bn ($1.890bn) to £1.332bn ($1.940bn).

This represents 13% operational revenue growth (calculated on a constant currency basis) and an increase of 11% on a reported basis, all compared to the prior year period.

The company achieved adjusted earnings per share of £0.19 ($0.28) for the period, compared to £0.14 ($0.21) a year ago.

Mike Mahoney, president and chief executive officer, Boston Scientific, said: "Four of our seven businesses achieved double-digit organic revenue growth this quarter, as the high performance of our global team has accelerated our growth profile as a company.

"This strong start enables us to raise our outlook for the year. We continue to execute on our product launches, expand into faster growth markets and deliver solutions that address unmet clinical needs."

Boston Scientific’s other first quarter financial results include:

First quarter operational revenue growth of 28% in MedSurg, 14% in Cardiovascular and a decline of 2% in Rhythm Management, all over the prior year period.

Received a national coverage decision from the Centers for Medicare and Medicaid Services that is consistent with the US Food and Drug Administration (FDA) label and will cover the Watchman Left Atrial Appendage Closure Device as a non-pharmacological treatment option for stroke risk reduction in patients with non-valvular atrial fibrillation.

Received FDA approval for the Acuity X4 Quadripolar Left Ventricular Leads.

Launched the AXIOS Stent and Electrocautery Enhanced Delivery System to help physicians manage two serious complications from pancreatitis using a minimally invasive, endoscopic approach.

Received CE Mark for, and began European commercialisation of, the Eluvi Drug-Eluting Vascular Stent System

Received FDA approval for the Blazer Open-Irrigated Radiofrequency Ablation Catheter

New Post has been published on science.tv.tr

New Post has been published on http://science.tv.tr/2016/05/27/albis-distributes-eastmans-amphora-3d-polymer/

Albis distributes Eastman’s Amphora 3D Polymer

Albis Plastic has acquired the rights to distribute Eastman Chemical's Amphora 3D Polymer AM1800 in Europe

× Expand

The low-odor, styrene-free material for 3D printing applications has high dimensional stability, low shrinkage and resistance to hydrolysis, according to Albis.

The material can be processed in most filament 3D printers and has a high layer-to-layer adhesion so that it can be used for functional parts as well as prototyping.

The material is also in conformity with the food contact and medical product regulations of the US Food and Drug Administration (FDA), as well as the equivalent food product regulations in the EU.

Heinz Wessendorf, director BL distribution advanced polymers at Albis Plastic, said: “3D printing offers us an expanded field of application possibilities thanks to the great freedom of design it provides and makes an outstanding addition to conventional processing technologies.

“We are pleased to be able to distribute these types for Eastman in Europe. To do so, we are expanding our Eastman portfolio and also offering a plastic solution which was specifically developed for this processing method for the first time.”

Thomas Steinbrecher, group leader technology EMEA for Eastman Chemical Specialty Plastics, said: “Eastman Chemical was early to invest in the development of functional, harmless to health polymers for professional 3D printing.

“Our cooperation with Albis Plastic enables us to competently serve our customers in the growing 3D printing market on a nationwide level,” notes.

New Post has been published on science.tv.tr

New Post has been published on http://science.tv.tr/2016/05/27/bds-blood-separation-technology-receives-ce-mark/

BD’s blood separation technology receives CE mark

Becton, Dickinson and Company (BD), a medical technology company, has obtained the CE mark in the UK and Europe for its next-generation blood separation technology

× Expand

BD Vacutainer Barricor tube is a single-use, plastic evacuated tube used to collect, separate, transport and process venous blood specimens to obtain high-quality plasma for in vitro diagnostic use, according to BD.

BD said its Barricor tubes are optimised to deliver a high quality plasma sample by reducing cellular content (vs. plasma gel tubes), as a result of the mechanical separator remaining open throughout the centrifugation cycle.

According to the American Journal of Clinical Pathology, with 60% to 70% of the required information on a patient’s chart coming from laboratory test results, there is a high demand for rapid test turnaround time among clinicians.

Mike Fairbourn, vice president and general manager, UK and Ireland at BD, said: “Laboratory technicians are forced to choose between a clean sample with serum and a fast sample with plasma.

“BD Barricor tubes eliminate this tradeoff, providing a cleaner and faster plasma sample than current methods.”

BD said its Vacutainer Barricor Plasma Blood Collection tube has separator technology that provides a cleaner plasma sample with less cellular contamination, meaning the sample is more stable and allows a longer window to conduct testing when compared to existing blood separation tubes.

New Post has been published on science.tv.tr

New Post has been published on http://science.tv.tr/2016/05/27/water-world-medical-applications-of-hydrogels/

Water world: medical applications of hydrogels

Jason Smith, senior analytical chemist, Polymer Solutions, looks at understanding necessary analytical techniques of hydrogel

× Expand

Man at work: A scientist at the GPC instrumentation

A hydrogel is like a molecular sponge. In looking at a hydrogel material one sees what looks like a solid form. However, the hydrogel has tiny pores throughout its structure that are interconnected to create a vast network of pathways for water and other small molecules to be absorbed and retained. Common uses of hydrogel materials include wound care management, aiding in tissue repair, drug delivery, cartilage replacement, and as the material of choice for contact lenses. While hydrogels have been utilised within the life sciences industry for over 50 years their increased use is poised to grow as these materials are better understood and tailored to have novel functional characteristics. Chemical analysis and physical testing of hydrogels ensures that the material will perform as expected and most importantly that it will be safe for the patient.

According to Gulrez et al (2011) there are three important characteristics for a hydrogel. These characteristics are the hydrogel’s water holding capacity and permeability, dissolution rate, and its biocompatibility.

First, the hydrogel must have the ability to hold water to be effective. Therefore knowing its capacity lets you know how much water the hydrogel bonds to the hydrophilic groups and how much water is bound through the materials hydrophobicity.

Secondly, when the hydrogel is in place it needs to either deliver or direct changes in the system. This means that small molecules need to migrate out of the hydrogel, as in drug delivery of active pharmaceutical ingredients (API), or that the hydrogel needs to dissolve, as in keeping an area moist for tissue repair. The dissolution rate itself must also be reliable and appropriate for the specific application.

Thirdly, the biocompatibility needs to be understood to ensure that the hydrogel can be degraded within the body without producing any toxic substances. The dissolution products should be processed normally by the body without complications.

Properties of hydrogels

Defining the hydrogel properties must be done carefully and methodically during the R&D phase, with analytical testing to confirm material performance. Once the desired properties are defined for a hydrogel, it is important to evaluate the quality of the end product through proper testing protocols. Validated test methods should be followed to assure the hydrogel will meet all critical performance specifications. There are multiple analytical options that should be considered for the testing of hydrogels during development, implementation, and commercial production.

Fourier Transform Infrared (FTIR) Spectroscopy is a non-destructive technique that allows the user to identify molecular species in a sample matrix. In order to determine if the correct polymer system is being used in the hydrogen, FTIR spectroscopy is employed to confirm the proper molecular structure. FTIR spectroscopy can also be used to confirm the identity of any other species that are present in the hydrogel material whether or not they are meant to be in the matrix.

Gel Permeation Chromatography (GPC) is utilised to determine the molecular weight distribution of a polymer or macromolecule. For hydrogels GPC is used to determine the molecular weight distribution of the non-crosslinked polymer fraction of the hydrogel. This analysis gives an indication of the crosslinking efficiency for the hydrogel polymer fraction.

Microscopy techniques can be used to look at surface characteristics of hydrogels. More specifically, Scanning Electron Microscopy with Energy Dispersive Spectroscopy (SEM-EDS) can be employed to look at surface of the hydrogel and to confirm composition of additives to the hydrogel matrix. Whereas TEM is utilised to look at structure, pore size, and dispersion of fillers in a hydrogel. This analysis can be utilised with a quality assurance application to ensure that the end product is uniform.

Water holding capacity

Hydrogel water holding capacity is an important property to understand fully, this is quantifying the components of the hydrogel and determining the amount that is water and the amount that is gel. This technique is done with a wet chemistry technique of immersing the hydrogel in water or mildly alkaline water and then drying off the water. The fraction that remains is the hydrogel content of the material.

Swelling determines how much water a hydrogel can hold. This is particular useful for wound care applications in which the hydrogel needs to absorb large amounts of fluid. It is also very relevant to industries that use hydrogels for hygiene applications such as adult incontinence products. To determine this, a hydrogel dried to it polymer fraction and then allowed to absorb water for twenty four hours and the weight change is calculated as the amount of swelling.

Importance of patient safety

Patient safety is always a critical consideration when developing products for the life sciences industry. After a hydrogel is produced it must be tested to ensure that no residual or unwanted compounds remain in the matrix that will be exposed to body tissues. There are impurities that could have a toxic effect at very low concentrations. Extracting the hydrogel in water or other suitable solvent and subsequent analysis is prudent. Extracts can be analysed by several chromatographic techniques to determine the molecular structure and concentration of residual solvents and chemicals that are present in the hydrogel matrix. Chromatographic techniques that can be utilised include high performance liquid chromatography (HPLC), liquid chromatography mass spectroscopy (LCMS), gas chromatography (GC), and gas chromatography mass spectroscopy (GCMS).

If the hydrogel is designed for drug delivery it must be tested for the presence and amount of the medication. The drug must be extracted with a suitable solvent and then identified and quantified by the appropriate technique such, as FTIR or LCMS or GCMS. Another important parameter to measure is the rate of drug extraction. If the drug is to be time released, leachables testing is utilised to determine the rate at which the medicaments or active pharmaceutical ingredients migrate out of the hydrogel matrix.

As the use of varying types of hydrogels increase, there is a need to define testing procedures that ensure the safe use of these useful polymer matrices. Understanding the structure and functionality that they contain is important to build the proper knowledge base. Hydrogels are poised to improve quality of life and promote better patient outcomes but can only do this when supported by great analytical science and the proper laboratory techniques.

REFERENCES

Syed K. H. Gulrez, Saphwan Al-Assaf and Glyn O Phillips (2011). Hydrogels: Methods of Preparation, Characterisation and Applications, Progress in Molecular and Environmental Bioengineering – From Analysis and Modeling to Technology Applications, Prof. Angelo Carpi (Ed.), ISBN: 978-953-307-268-5, InTech, Available from: http://www.intechopen.com/books/progress-in-molecular-and-environmental-bioengineeringfrom-analysis-and-modeling-to-technology-applications/hydrogels-methods-of-preparation-characterisationand-applications

New Post has been published on science.tv.tr

New Post has been published on http://science.tv.tr/2016/05/17/northern-powerhouse-receives-10-8bn-from-life-science-companies/

Northern Powerhouse receives £10.8bn from life science companies

The published data also showed that there are 1,000 life and health science companies in the Northern Powerhouse, with SMEs making up 97% of these companies.

It was also revealed that these companies manufacture and export over £8.1bn of medicinal and pharmaceutical products per year.

Announcing the data at the BioTrinity Conference in London, life sciences minister, George Freeman, said: “This data shows that the UK’s £56 billion life sciences industry is a powerhouse in the Northern economy.

“Through our life sciences strategy we are creating jobs, opportunities and security across the North. With its world-leading universities, innovative life sciences companies and millions of NHS patients across the region, the North has unique capabilities with excellent growth potential for international investors.”

The statistics originate from the 2015 Strength & Opportunity Report. The data forms part of a new Northern Powerhouse life sciences brochure created to drive inward investment into the thriving life sciences sector in the North.

The work was commissioned by UK Trade & Investment (UKTI) and was created in collaboration with the Northern Health Science Alliance (NHSA).

NHSA chair, and vice-president and dean of The University of Manchester’s Faculty of Medical and Human Sciences, Ian Greer said: “The great universities and NHS organisations of the North have been working collaboratively with each other and industry to establish some of the most advanced facilities populated by world-leading experts in their field.

“Together with a 15 million population there is a massive untapped resource for international investors and industry to work with the Northern Powerhouse for mutual benefit.”

The brochure showcases the world class facilities that the North has to offer such as:

The £38m National Biologics Manufacturing Centre within the Centre for Process Innovation (CPI) which will host the £20m CPI Biologics Factory of the Future.

The UK Antimicrobial Resistance Centre – a £4 million investment in AMR therapeutics development Medicines Discovery Catapult – worth £4 million the Catapult is a joint private-public initiative to support the development of new antibiotics and diagnostics through a fully integrated development capability, offering translational R&D from pre-clinical hits through to clinical proof of concept

Alderley Park in Cheshire – With over £550 million invested by AstraZeneca in world-class facilities and infrastructure over the past decade, Alderley Park is one of the best invested bioscience R&D sites in Europe.

The North also boasts one of the Europe’s strongest clusters in biological, medical and surgical manufacturing with Eli Lilly, Allergan, Fujifilm Diosynth Biotechnologies, Seqirus, JRI Orthopaedics, and DePuy Synthes based there.

New Post has been published on science.tv.tr

New Post has been published on http://science.tv.tr/2016/05/17/raumedic-introduces-its-new-us-site/

Raumedic introduces its new US site

Raumedic has constructed a growth and manufacturing middle in Mills River, North Carolina, four,600 Miles (7,300 km) away from the corporate’s German headquarters.

Throughout the first stage of growth, customised tubing, molded elements and programs shall be produced on thirteen,000 sq. toes of fresh room house in accordance with ISO 14644 class 7, in keeping with Raumedic.

Raumedic chairman, Martin Bayer, mentioned: “After solely seven months of development, with our new house for Raumedic, all of us have created an American firm that’s based mostly by itself custom and historical past.

“We are going to fuse and develop German and American know-how in polymer processing on this area.”

The corporate is investing over £thirteen.7m ($20m) in its new US headquarters.

New Post has been published on science.tv.tr

New Post has been published on http://science.tv.tr/2016/05/17/4-things-to-think-about-when-choosing-a-high-performance-polymer/

4 things to think about when choosing a high performance polymer

In the present day’s medical system designers and unique tools producers (OEMs) are more and more underneath strain when creating or bettering medical units. One of many greatest selections they make is choosing a cloth for his or her system — the proper alternative helps meet the top-consumer’s wants whereas the fallacious alternative can result in points later.

Excessive-efficiency polymers are the way forward for medical units, as they assist higher tackle affected person wants and last more. Nevertheless, the selection doesn’t finish there. Key issues nonetheless should be made when choosing probably the most applicable excessive-efficiency polymer for gadget design. These concerns typically embrace making certain the fabric affords chemical resistance, sterilisation stability, design flexibility and superior readability.

One other key consideration is discovering a provider that provides way more than only a product. From venture initiation to product launch, providing technical experience and sharing utility improvement insights can assist guarantee a excessive-performing polymer is true for a particular gadget.

Verify the bins

A guidelines is the best manner to make sure a fabric is assembly a tool’s each want, particularly when navigating the numerous benefits of excessive-efficiency polymers. Cipher Surgical made positive to examine all the packing containers when enhancing its OpClear machine, finally deciding on Eastman Tritan copolyester. To eradicate the necessity to take away a laparoscope from a affected person throughout surgical procedure, OpClear permits a surgeon to wash the lens of collected liquid, fatty residue and different contaminants with a brief, managed jet of carbon dioxide and saline. By lowering, and even eliminating, the need to take away the laparoscope for cleansing, the gadget reduces operative time and maximises affected person security.

1. Will your gadget want to resist contact with harsh medicine and damaging disinfectants?

As extra hospitals are pushing to cut back instances of infections and treating sufferers with the perfect medicine obtainable, many units want to have the ability to face up to aggressive disinfectants and harsh medication, reminiscent of these used for oncology sufferers, with out breaking down. In truth, hospitals are standardising using harsh disinfectants of their processes to make sure simplicity and consistency.

Though the primary era of OpClear was successful, the gadget was made with nylon, which reacted poorly to sure cleansing chemical compounds, inhibiting the product’s full potential. To stop the system’s early breakdown, Cipher selected Eastman Tritan copolyester for his or her subsequent-era system. The fabric is immune to a big spectrum of fluids utilized in hospitals, together with aggressive cleansing disinfectants, highly effective medication together with these utilized in oncology, drug provider solvents and lipids. This resistance helps lower the danger of the gadget cracking and discolouring, due to this fact growing affected person security.

2. Will your gadget have to bear sterilisation and are available out unscathed?

Many units utilized in hospitals must endure sterilisation processes — akin to e-beam, gamma radiation and ethylene oxide (EtO) strategies – to cut back the bioburden to a secure degree whereas additionally minimising adjustments to the ultimate product’s bodily and optical properties. These processes can have an effect on a tool’s color and readability, and in addition trigger cracking and lack of crucial properties. A cloth should be capable to stand up to sterilisation processes and stay unscathed after repeated makes use of.

When redesigning OpClear, Cipher wanted a cloth with sterilisation stability as a result of the system underwent these processes prior to each use. Eastman Tritan copolyester is proof against sterilisation methods with out jeopardising the polymer efficiency, providing no danger of color shift to yellow – which may trigger units to be seen as contaminated – and no bodily property malfunctions.

three. Will it is advisable see the substances inside your gadget?

Gadgets constituted of crystal-clear materials present healthcare personnel with unobstructed views that permit them extra simply — and rapidly — see international substances, bubbles, fibres from sanitising cloths and fluid ranges, which helps maintain sufferers secure.

For OpClear, a cloth with superior readability allowed for visible affirmation that the machine was working, in addition to helped preserve the laparoscope visually much like what surgeons are used to. Eastman Tritan copolyester supplied the readability Cipher was in search of, particularly as the fabric stays simply as clear after the system’s meant use and sterilization.

four. Will you want extra help by way of technical experience and utility improvement?

To higher perceive how a fabric may be labored to suit particular design wants and the way it ought to be examined, designers and OEMs can think about aligning with established firms which have experience in these new supplies and are keen to work collectively. Collaboration from the onset — and all through the worth chain — may help guarantee the proper materials is chosen, the design course of runs easily and the product is delivered to market as seamlessly as potential.

o enhance the unique OpClear, Cipher labored intently with Eastman’s technical and software growth specialists and people from moulding firm Ci Medical Applied sciences. The collaboration ensured every firm’s experience was used to optimise the moulding course of with the brand new materials.

Reviewing the guidelines

Entry to excessive-efficiency polymers that higher handle buyer and finish-person wants permits designers and producers to fulfill the rising demand for medical system innovation. With some easy issues – and by utilizing a simple guidelines to ensure a cloth meets a tool’s wants – designers and OEMs can higher assess which materials is correct for them.

New Post has been published on science.tv.tr

New Post has been published on http://science.tv.tr/2016/05/02/j-pac-medical-boss-talks-company-plans/

J-Pac Medical boss talks company plans

MPN: What plans do you could have for J-Pac’s development technique this 12 months?

JB: J-Pac Medical has been well-known for its capabilities in sterile packaging for a few years. Our plans are to lift market consciousness for the corporate’s different important capabilities. J-Pac has in depth experience and expertise in manufacturing Class III implantable textile units that require precision forming and particulate-free reducing. J-Pac has been a pioneer in enabling level-of-care diagnostics via its lab-on-chip reagent blister expertise that utilise frangible seals. The corporate additionally each manufactures and packages completed sterile gadgets, together with dry-room processing of environmentally delicate medical merchandise. In all these markets, J-Pac brings a compelling worth proposition primarily based on technical competence, execution and worth.

MPN: In what approach will your earlier expertise be put to make use of in your new function?

JB: I’ve greater than 25 years of expertise constructing excessive-progress medical product-based mostly corporations like GI Provide, Optim, Haemonetics and Side Medical Programs, which was acquired by Covidien. I perceive the challenges of main an organization in immediately’s healthcare area and know find out how to implement profitable development methods whereas driving operational excellence. At the moment’s medical machine market is all about worth. OEMs have to ship merchandise that present confirmed affected person worth – each clinically and economically. This requires that offer chain companions resembling J-Pac mirror these attributes by producing the best high quality merchandise, on-time, and at a worth that allows each events to achieve success.

I believe J-Pac Medical is ripe for development and brings lots to the desk when it comes to what it could possibly do for its clients. My collective expertise will serve me nicely in managing a excessive efficiency administration crew; growing and implementing optimised working infrastructure and manufacturing processes; and bettering present product pipelines and rising new ones for J-Pac.

MPN: What new initiatives do you could have deliberate for 2016?

JB: We’re closely investing in including extra medical machine capabilities and increasing our current manufacturing providers for units utilized in orthopaedics/backbone, sports activities medication, and cardiovascular procedures. We additionally plan to have a big announcement later this yr for a brand new and probably floor-breaking implant.

Moreover, we’re touting J-Pac’s dry room processing capabilities for the packaging of environmentally-delicate healthcare merchandise. J-Pac’s dry room capabilities characteristic low humidity processing in Class 7 cleanrooms with choices for each high and low quantity purposes.

2016 can even carry important adjustments in our manufacturing methods as we proceed enhancing effectivity, high quality, and on-time supply.

MPN: The place do you see the corporate this time subsequent yr?

JB: We would like individuals to see J-Pac Medical because the go-to worth added contract companion not only for their medical packaging however for just about all of their outsourced wants. Whether or not they want assist with implantable textiles, lab-on-chip reagents, thermoformed packaging or medical gadgets, we have now the capabilities and experience to help innovation from the inception of an concept by the product growth throughout the phases of the availability chain.

We hope extra medical machine corporations and OEMs know our identify and recognise the worth of what we will do for them.

New Post has been published on science.tv.tr

New Post has been published on http://science.tv.tr/2016/04/23/aggressive-bidding-toshiba-sells-entire-medical-device-business/

Aggressive bidding: Toshiba sells entire medical device business

Rising restructuring costs of Toshiba Corp, which is dealing with the aftermath of an accounting scandal, have prompted administration to advertise Toshiba Medical Strategies in its entirety, reported Reuters.

Toshiba Medical makes diagnostic instruments corresponding to X-ray and magnetic resonance imaging (MRI) strategies and is the world’s second-best producer of CT scan machines.

Reuters reported that the value tag between 4 hundred bn yen to 500 bn yen (£2.5bn to £three.2bn) was an inexpensive value for the unit nevertheless that the deal price would possibly go as extreme as 650 bn yen (£4.1bn) amid sturdy demand for medical corporations with extreme progress prospects.

Companies much like Mitsui and Kohlberg Kravis Roberts (KKR), proprietor of Panasonic Healthcare Holdings, are collaborating in an effort to make bids on Toshiba healthcare, whereas Canon is looking for to make a bid by itself.

Toshiba Medical represents “a as quickly as-in-a-lifetime different, and we’re ready to purchase it,” Toshizo Tanaka, Canon’s authorities vice chairman, talked about in a info conference.

KKR, Canon, Fujifilm Holdings and Konica Minolta, Japanese imaging firms with medical machine objects, have been shortlisted for the second spherical of bidding, Reuters acknowledged. The deadline for the bids is Friday 4 February.

Toshiba launched it is planning to advertise each a controlling holding or the entire stake nevertheless thus far has not specified which and primarily based on Reuters, it expects to have made a web lack of 710 bn yen (£4.5bn) for the 12 months ending in March in distinction with a earlier estimate of a 550 bn yen (£three.4bn) loss.

New Post has been published on science.tv.tr

New Post has been published on http://science.tv.tr/2016/04/23/in-profile-jim-tenbrink-encoris/

In Profile: Jim TenBrink, Encoris

Price stream: Jim TenBrink says that Encoris helps medical gadget companies decrease costs, and enhance some great benefits of their medical models

MPN: Who’re you and what do you do?

JT: Encoris is a fast rising medical modelling agency located on the attractive shores of Lake Michigan.

Our agency develops and manufactures medical product sales demonstration / affected individual coaching fashions and surgical trainers for commerce current reveals, medical system promotion and medical coaching.

Encoris is not going to be your off-the-shelf, typical agency – we customise product choices that help medical system companies decrease costs, differentiate and enhance the choices and benefits of their medical items.

MPN: What initiatives have you ever ever been centered on not too way back?

JT: An Italian faculty, which serves as an incubator for surgical teaching model ideas, has initiated an settlement with Encoris to develop, manufacture and commercialise surgical teaching fashions world-giant. The first enterprise features a redesign on a patented ultrasound kidney coach for PCNL teaching.

Given our knowledge of life-like provides and mildew-making processes, we’re enhancing the model to supply increased anatomical and tactile realism, to be further shopper nice and have a for for much longer shelf life.

The model is a non-natural, re-usable, ultrasound and X-ray applicable and it might be tailor-made for numerous types of renal shows – hydronephrotic, staghorn stone, larger or lower caliceal stones, and so forth.

The model has already been used and appreciated on the EULIS Masterclass in Milan.

We’re moreover at current engaged on making a partnership with a German based totally agency who strictly creates anatomical foam fashions.

The company sought Encoris for our top quality clear medical fashions and is considering the possibility of cataloguing and distributing our clear bone fashions to its distributors.

MPN: Describe your latest innovation?

JT: Now we’ve patented a surgical teaching model platform designed to revolutionise the way in which through which surgeons put together on the newest medical devices and surgical procedures.

Using the newest app utilized sciences and life-like delicate tissue provides, the encOR-m.i.s. Surgical SmartTrainer (SST) ensures to make important developments in orthopedic surgical teaching, notably for minimally invasive surgical process (MIS).

Termed ‘OR in a area’, the coach is all-encompassing, providing x-ray-like illuminated anatomy and in-constructed pathologies offering a arms-on teaching experience for surgical placement of medical implants.

Constructed into the model’s CPU is a personalised web app that works along side laptop computer-pushed seen aids, allowing trainees to see full A/P/L visuals of the inside, intricate particulars of the surgical course of.

The proprietary app captures precise-time video feed and wirelessly reveals the surgical footage onto a password-protected website online, viewable on any desktop, iPad, capsule, or smartphone system – an unlimited plus for commerce current venues with large crowds or educators who can now current distant teaching via the online to distributors and surgeons worldwide.

Utilising the latest app software program program and visual utilized sciences, coupled with anatomic life-like realism, medical system companies in the meanwhile are able to soundly and cheaply current and observe the newest M.I.S. strategies with out the logistical limitations, expense and radiation hazards of typical cadaveric teaching.

One different innovation is called FlexClear bones. With reference to workshop teaching, the rivals gives one-time use foam bones for demonstrating surgical functions of medical implants.

The froth bones are dusty and brittle. They’re moreover steady and totally conceal the distinctive choices of the implant the educator is making an attempt to show. FlexClear bones, being made out of pliable urethane, are versatile and clear.

Using CAD design, pathways for placing the implant will likely be created and moulded correct into the bone anatomy or the patron can drill or faucet the bone fashions themselves.

Each strategy, FlexClear bones are repeatable and permits the surgeon to have a additional smart, palms-on, seen experience when demonstrating an implant.

MPN What does it indicate for the medical sector?

JT: The manufacturing course of we use to develop our fashions is unique to Encoris and has benefited the medical sector successfully.

Using CAD and 3D printing saves our medical system buyers a range of time and money; with the ability to create 100% right fashions in precise time, has given our prospects peace-of-ideas that their merchandise and duties will doubtless be manufactured precisely and on time.

Working with appropriate fashions brings a few additional educated, safer, further assured surgeon, which lastly brings higher peace of ideas to victims the world over.

In addition to, our medical fashions help larger current and show the choices and benefits of a medical gadget, which empowers our medical system prospects with bigger confidence to advertise and educate surgeons on the latest utilized sciences.

MPN: Plans for the long term?

JT: As Encoris’ providers and merchandise proceed to develop in repute, demand for fashions exterior of the orthopaedic market will develop in areas akin to fundamental surgical process, ultrasound teaching, gynecology, minimally invasive surgical process, dental, and veterinary medication.

With the persevering with developments of our Surgical Smart Coach experience, hospitals and medical entities alike will someday have the ability to remotely assess a surgeon’s skill diploma on a selected surgical course of and implement obligatory corrections in an effort to reduce the chances of medical malpractice.

We’re in a position to moreover see this know-how getting used for battlefields or any ambiance the place emergency medical/surgical consideration is required.

New Post has been published on science.tv.tr

New Post has been published on http://science.tv.tr/2016/04/22/sperm-whale-foreheads-may-be-specialized-for-ramming/

Sperm whale foreheads may be specialized for ramming

Ever since a sperm whale (Physeter macrocephalus) head-butted and sunk a whaler’s ship in 1821, whalers and scientists have theorized that the mammals’ uniquely boxy foreheads is maybe tailor-made for use as battering rams—most likely for male-on-male battles over entry to females. Nevertheless not all people agrees, significantly on account of the buildings that shall be entrance and coronary heart in an impression are important for producing the whale’s clicking communication. In a model new analysis, researchers examined the thought by working digital crash exams: Using a model of a sperm whale skull constructed using already revealed info, they simulated ramming impacts, and recorded the place inside the skull these impacts produce basically probably the most mechanical stress. To have a look at the place of interior buildings, the researchers moreover eradicated the vertical tissues that divide up the massive, oil-stuffed organ generally known as the “junk” in some fashions. The simulations confirmed that these junk compartments help unfold the drive of affect over the skull, and eradicating the compartments increased overall stress on the skull by 45%. Plus, the compartment tissues are thickest near the doorway of the skull—the similar house the place have an effect on forces are primarily essentially the most intense, the authors report at current inside the journal PeerJ. Male ramming habits has solely been observed as quickly as in sperm whales. Nevertheless based on their ram-ready skulls, the authors say, these contests is also occurring below the ground.

Original Article

New Post has been published on science.tv.tr

New Post has been published on http://science.tv.tr/2016/04/21/theres-no-scientific-validity-to-this-dangerous-idea-yet-most-of-us-are-probably-guilty-of-it/

There's no scientific validity to this dangerous idea - yet most of us are probably guilty of it

NASA HQ PHOTO/Flickr

“There’s actually no such factor as race,” world-well-known scientist, creator, and tv character Invoice Nye advised Big Think in 2015. “There’s completely different tribes however not totally different races. We’re all one species.”

Even if there’s no scientific foundation for the thought of racial variations – a degree hammered house by the sequencing of the first human genome, or full set of DNA, in 2003 – we proceed to see ourselves as distinct alongside racial strains. And these perceptions have actual penalties, each by way of particular person behaviour and institutional insurance policies.

Scientific analysis means that the overwhelming majority of us are extremely conscious – consciously or subconsciously – of racial variations and, whether or not we would like it to or not, this data performs a key function in empathy.

Of their 2009 paper in The Journal of Neuroscience, researchers at Peking College did an experiment by which they confirmed white and Chinese language college students clips of white and Chinese language faces each in ache and never in ache whereas they measured their mind exercise utilizing practical magnetic resonance imaging (fMRI).

The researchers have been paying specific consideration to mind exercise in an space of the mind referred to as the anterior cingulate cortex (ACC), which scientists suppose performs a key position in registering our personal ache and empathy for an additional particular person’s ache.

For all the individuals, ACC exercise was considerably greater whereas they had been viewing painful expressions on the face of somebody of their very own race, and decrease after they seen ache on the face of one other race. The outcomes have been in accordance with the speculation the researchers began with – that social relationships between people affect empathic responses, the place a person experiences increased empathic responses for these in the identical perceived social class.

For a 2010 study printed within the journal Present Biology, researchers on the Division of Psychology on the College of Bologna carried out a two-half take a look at on teams of white Italians and black Italians.

For the primary a part of the check, they requested the volunteers to match ‘good’ and ‘unhealthy’ phrases with pictures of black and white faces. For the second half, they confirmed the contributors pictures of a black, white, and purple hand being pricked with a needle whereas they examined neural response to the ache utilizing by stimulating the motor cortex of the mind. The upper the empathic response, the larger the response to the stimulation.

Curiously, whereas each white and black volunteers confirmed satisfactory response to the stimulation whereas they watched the purple hand being pricked, neither teams confirmed as a lot exercise after they watched a hand of somebody exterior their racial group being pricked.

Moreover, those that tended to match extra ‘good’ phrases with photos of individuals from their very own racial group and extra ‘dangerous’ phrases with one other racial group (which instructed what the researchers known as implicit racial bias) had even decrease neural response whereas watching a hand of the alternative race being pricked.

Nobody needs to imagine that she or he is racist. Nonetheless, there’s sufficient conclusive proof to counsel that the overwhelming majority of us are both consciously or sub-consciously much less empathetic towards individuals of different races.

Whereas it’s arduous to regulate subliminal responses, a aware effort to behave with out bias may very well be a solution to fight the surreptitious racism. Or possibly elevated interactions with totally different ‘races’ might assist our brains see that we’re ninety nine.9 % the identical.

Trending Blogs

Recently Viewed Blogs

İsimsiz